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ABSTRACT 
Objective:  To determine whether differences in race and ethnicity affect the usage of 
dermatological services. 
Methods: Data from the National Ambulatory Medical Care Survey were used to study trends in 
ethnic/race rates of outpatient dermatology office visits among publicly and privately insured 
patients from 2005-2010. In multivariable models, we explored the magnitude of ethnic/race 
differences in dermatology visit attendance for patients with public vs. private insurance. 
Results: From 2005-2010, dermatology visit utilization increased among insured Hispanics, but 
not among insured non-Hispanic Blacks or whites. Visits were less frequent by those with public 
insurance compared to private insurance. Privately and publicly insured visits were less common 
for non-Hispanic Blacks and Hispanics compared to whites after adjustment for patient 
demographics and primary visit diagnosis. Racial and ethnic differences in visit utilization rates 
were most apparent among non-referred visits. However, primary diagnoses for non-referred 
visits were similar across races and ethnicities, which suggests that differences in utilization may 
result from factors unrelated to clinical indications for care. 
Conclusion: Ethnic/race differences in the use of dermatological services in the United States 
may result from patient preferences for dermatologic care or health system related factors (e.g., 
insurance coverage regulations). 
 
Keywords: Race, ethnicity, health disparities, office visits, dermatology, and health services 
accessibility, Medicare, Medicaid, predictive value of tests 
 
 
INTRODUCTION 
The National Healthcare Disparities Report cites healthcare utilization as an important 
indicator for the successful or unsuccessful attainment of adequate health care services (Bonito, 
Eicheldinger, Evensen, & Lenfestey, 2005). Racial and ethnic differences in the incidence, 
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prevalence, morbidity and mortality of various skin conditions have been documented (Davis et 
al., 2012), yet relatively little is known of the role of dermatologic services in directly 
influencing those differences. For example, while age-adjusted melanoma incidence is 
considerably higher among whites than ethnic and racial minorities, minorities diagnosed with 
melanoma are two to four times more likely than whites to receive an advanced stage diagnosis 
(Cormier et al., 2006). One study demonstrated that minorities are more likely than whites to 
have common dermatologic conditions such as psoriasis go undiagnosed, suggesting potential 
racial differences in the receipt of quality dermatologic care (Kurd & Gelfand, 2009). It is critical 
to know if this contrast in outcomes is attributed to variations in patient access to dermatologic 
care, particularly for life threatening conditions such as cutaneous melanoma, which requires 
early detection and timely access to high quality dermatologic attention.  
Health insurance, a major determinant of patient access to care (Baker, Shapiro, & Schur, 
2000; Burstin, Swartz, O'Neil, Orav, & Brennan, 1998; Ku & Matani, 2001; Newacheck, 
Stoddard, Hughes, & Pearl, 1998), substantially influences patients’ use of health care services 
and outcomes (Fiscella, Franks, Doescher, & Saver, 2002; Lillie-Blanton & Hoffman, 2005; 
Sudano & Baker, 2006; Zuvekas & Taliaferro, 2003). Lillie-Blanton and Hoffman found that 
health insurance was the chief factor to interact with race/ethnicity, and played a major role in a 
person’s ability to obtain high quality health care (Lillie-Blanton and Hoffman, 2005). Little is 
known about the influence of health insurance status, and its various forms (private vs. public, 
which differ in their benefit structures and restrictions for dermatological services) on 
racial/ethnic differences in the frequency of dermatology visits. We studied racial/ethnic patterns 
in the utilization of US office-based dermatology visits among privately and publicly insured 
patients. Based on recent reports of less access to specialty services by minorities and individuals 
with public insurance we hypothesized that disparities in utilization of dermatological services 
would either decrease or remain unchanged throughout the study period. 
 
METHODS 
Overview 
We studied trends and predictors of dermatologic service use among insured ethnic and 
racial minority and non-minority patients in the US for 2005-2010 using the National 
Ambulatory Medical Care Survey (NAMCS). We hypothesized that ethnic and racial minorities 
would utilize dermatology services less frequently than their non-minority counterparts and that 
predictors of dermatologic service use would vary between ethnic and racial groups. 
Data Source 
The NAMCS is conducted by the National Center for Health Statistics (NCHS) of the 
Centers for Disease Control and Prevention (CDC) to provide data on the characteristics of 
health care provided by non-federally funded US office-based physicians. The system measures 
utilization across a broad spectrum of medical and surgical specialties, including Dermatology. 
These data estimate outpatient services utilization on an annual basis and are ideal for studying 
the use of dermatology services in the US because of the large representative sample size, the 
validated quality checks throughout the survey process, the broad base of information across 
various geographic regions (Licciardone & Singh, 2011) and the ability to calculate national 
estimates and associated standard of errors using survey weights (Barnett, Song, & Landon, 
2012). 
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To obtain a representative cross-section of ambulatory visits, the NAMCS employs a 
multi-stage sampling design (Cherry, Hing, Woodwell, & Rechtsteiner, 2008; Cherry, 
Woodwell, & Rechtsteiner, 2007; Hsiao, Cherry, Beatty, & Rechtsteiner, 2010; Statistics, 2011a, 
2011b). The system applies several weighting procedures to produce nationally representative, 
unbiased results, including inflation by reciprocals of the probability of selection (Cherry, et al., 
2008; Cherry, et al., 2007; Hsiao, et al., 2010; Statistics, 2011a, 2011b), adjustment for non-
responses, ratio adjustment to fixed totals and weight smoothing (Cherry, et al., 2008; Cherry, et 
al., 2007; Hsiao, et al., 2010; Statistics, 2011a, 2011b). A patient record form, completed by 
physician/medical office personnel or abstracted by US Census Bureau field representatives, 
documents each patient’s race/ethnicity, gender, reason for visit, physician diagnosis for the visit, 
diagnostic screening services, health education, non-medication treatment, provider type, patient 
method of payment, and physician disposition. Medical coding and data processing were 
performed by SRA International of Durham, NC. Coding error rates were usually less than 5 
percent (Cherry, et al., 2008; Cherry, et al., 2007; Hsiao, et al., 2010; Statistics, 2011a, 2011b). 
 
Visit Characteristics 
We identified insured dermatology visits as those coded within the specialty of 
dermatology for both children and adults and for which at least one type of health insurance was 
listed. We examined the use of dermatologic visits among ethnic and racial minorities (defined 
as non-Hispanic Blacks [NHB], non-Hispanic other and Hispanics) and non-minorities (defined 
as non-Hispanic whites [NHW]) and excluded “non-Hispanic other” patients from analyses due 
to the small number of visits. The NCHS uses various methodologies to impute missing data for 
race and ethnicity. Using a new method adopted in 2009, race/ethnicity were imputed using a 
model-based sequential regression method. The main predictors for missing race/ethnicity were 
Census variables of zip code level race and ethnicity population estimates. The proportion of 
imputed data varied by year for both race and ethnicity and ranged 21-33% (white, Black, Other) 
for race and 22-34% for ethnicity (Hispanic or Latino/non-Hispanic) (Cherry, et al., 2008; 
Cherry, et al., 2007; Hsiao, et al., 2010; Statistics, 2011a, 2011b). We also recorded other 
demographic characteristics of patients attending dermatology visits, such as age (<65 and 65 
years old), gender, geographic characteristics (South, Northeast, Midwest, and West) and 
expected sources of insurance payment, including private or public (Medicare, Medicaid, and 
State Children’s Health Insurance Plan [SCHIP]). Based on NCHS guidelines, a hierarchal 
scheme was used to categorize the primary source of payment with Medicare, Medicaid or 
SCHIP recorded as public and all other insured visits recorded as private. We excluded 
20,165,151 visits where payment was recorded as “Workers’ Compensation,” “Self Pay,” “No 
Charge/Charity,” “Other,” “Unknown” or “Blank.” We also examined visits by referral status. 
Visits with referral status coded as “not referred” or “not applicable” were classified as “not 
referred.” Visits were excluded from analysis when referral status was designated as unknown or 
left blank. Primary diagnoses were recorded based on the International Classification of 
Diseases, Ninth Revision, Clinical Modification codes (ICD-9-CM). To achieve adequate sample 
sizes, we grouped the 14 most common ICD-9-CM codes for primary diagnosis into three 
categories: 1) malignant and premalignant (including actinic keratosis, malignant neoplasm of 
the skin site unspecified, personal history of malignant neoplasm and malignant neoplasm of skin 
of the face); 2) inflammatory dermatoses (defined as psoriasis, acne, dermatitis unspecified cause 
and rosacea); and 3) other (defined as benign neoplasm of the skin site unspecified, seborrheic 
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keratosis, verruca, neoplasm of uncertain behavior, sebaceous cyst, unspecified disorder of the 
skin and subcutaneous tissue). After excluding those visits with primary diagnoses not in the top 
14, 76.4% of visits remained for the comparative analyses.  
 
Statistical Analyses 
Annual trends in office visits among minorities and non-minorities. To explore the annual 
trends of visits to dermatologists by payment source, we used logistic regression modeling 
probability for each patient visit. The dependent variable of the model was defined for each visit 
by the binary variable DERM with values of 1 if a patient visited a dermatologist and 0 
otherwise. The association between survey year, patient race and ethnicity and primary payment 
type was represented by interaction terms between the continuous variable YEAR and 
categorical variables RACEETH (1- NHW; 2- NHB; 3- non-Hispanic others; 4-Hispanics) and 
PAYTYPE (1-Public insurance; 2- Private Insurance). To adjust for possible discrepancies in 
patient characteristics between survey years, the logistic model included covariates of patient age 
(AGE), sex (SEX), Census region (REGION), metropolitan area or rural locality (MSA = 1- 
Metropolitan area, 2- non-Metropolitan area) and primary diagnosis (DIAGNOSIS = 1- pre-
malignant and malignant neoplasm, 2- inflammatory dermatoses and 3- other diagnoses). As a 
result, the following logistic regression model was used to identify annual trends in the 
proportion of visits to dermatologists for minorities and non-minorities by payment source: 
 
logit (P[DERM=1[) =   α + β1*AGE + β2*SEX + β3*REGION + β4*MSA + β5*DIAGNOSIS +  
β6*REFERRED+ β7*RACEETH + β8*PAYTYPE+ β9*YEAR*RACEETH*PAYTYPE 
 
Because patient’s race and ethnicity variable is defined at four levels and the primary type of 
payment variable has two levels (see above), cross-tabulation of RACEETH and PAYTYPE 
defines eight groups of patients. For each group, corresponding estimates of β9 become available 
from the model, along with the p-values for t-statistics for checking the null hypothesis (no 
annual trend). Therefore, the annual trend of visiting dermatologists can be estimated separately 
for each of these eight groups. We considered the annual trend for a particular group of patients 
to be statistically significant if the corresponding estimated model coefficient β9 was statistically 
significantly different from 0 at the p = 0.05 level.  
Association of patient characteristics with visit attendance. We pooled data from 2005 to 
2010 in order to achieve a greater efficiency of estimates and to increase the power of statistical 
analyses. Aggregation of data was necessary because visits to dermatologists constitute only 
3.6% of the total number of office-based visits. Additionally, because we were interested in 
estimates for subgroups of the sample population, visits from just one year of data would not 
provide enough information to produce estimates with a reasonable degree of reliability.  
For all insured visits, we described patients’ demographic characteristics, including their 
race/ethnicity (NHW, NHB, and Hispanic/Latino), age, gender, the geographic region of visit 
(Northeast, Midwest, South or West), whether the region was considered a metropolitan 
statistical area, whether visits occurred as a result of a referral, and the primary diagnosis 
(premalignant and malignant, inflammatory or other) listed for the visit. We further stratified 
descriptions according to insurance type (public or private). We calculated the weighted totals 
and percentages for visits to dermatologists and the standard errors for all estimates, accounting 
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for the stratified multi-stage sampling design and using Taylor series linearization for non-linear 
estimates. 
We used logistic regression models to estimate the adjusted odds ratios (AOR) for 
dermatology visits by minorities compared to non-minorities, for all visits, for referred and non-
referred visits, with patient race/ethnicity as the categorical covariate of interest. AORs between 
NHW, NHB and Hispanics were estimated as an exponent of the corresponding model 
coefficient and were adjusted for potential confounders including patient age, gender, geographic 
region, MSA status and primary diagnosis. In order to explore the relationship between patient 
race/ethnicity and primary payment type, we included in the model interaction term 
RACEETHN*PAYTYPE and calculated AORs between l levels of RACEETHN for a given 
level of PAYTYPE: 
 
logit (P[DERM=1]) =   α + β1*AGE + β2*SEX + β3*REGION + β4*MSA + β5*DIAGNOSIS +  
β6*REFERRED + β7* RACEETHN + β8*PAYTYPE + β9*RACEETHN*PAYTYPE. 
 
For every level of cross-tabulation between categorical variables RACEETHN and 
PAYTYPE, there is a separate estimated value of β9 (RACEETHN, PAYTYPE). The AOR 
between, for example, Hispanics (RACEETHN=4) and NHW (RACEETHN=1) with public 
insurance (PAYTYPE=1) is calculated as exp[β9(4, 1) - β9 (1, 1)]. Estimated AORs cannot be 
expressed as explicit functions of other simple statistics, such as totals. To calculate their 
variances and confidence intervals (CIs) accounting for the sampling design, we used the Binder 
(Binder, 1983) approach. We tested hypotheses of non-zero contrast of AOR to visits between 
minorities and non-minorities at the p = 0.05 level of significance. To account for the complex 
survey design, we used Rao-Scott (Rao & Scott, 1981) approximations for statistical hypotheses 
testing. Statistical analyses were performed using SAS 9.2 (SAS Institute, Cary, NC) and 
SUDAAN 11 (Research Triangle Institute, NC). 
 
RESULTS 
Visit Characteristics from 2005-2010 
From 2005 to 2010, 190,612,400 outpatient visits to dermatologists occurred among 
insured US patients. Of those, NHW made 165,469,000 visits, NHB made 9,704,400 visits and 
Hispanics made 10,423,200 outpatient visits. Publicly insured visits accounted for approximately 
one-third of insured dermatology visits. Figures 1a and 1b illustrates the proportion of all 
outpatient visits for dermatology services by racial/ethnic group for each year from 2005 to 
2010. The proportion of visits for all primary dermatologic diagnoses increased significantly for 
Hispanics (β = 0.19, p = 0.003) with private insurance during the study period. For Hispanics 
with public insurance and NHB with either private or public insurance, differences in utilization 
did not change significantly over time (Figure 1).  
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Figure 1a: Proportion of Office Visits Made to Dermatologists Among Patients with Public 
Insurance. 
 
The proportional utilization by race/ethnicity and source of payment demonstrates that differences in utilization did 
not change significantly over time for Hispanics and non-Hispanic Blacks with public insurance. The number for 
publicly insured dermatologic and non-dermatologic visits totaled 803,638,300 during 2005-2010 study period. 
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Figure 1b: Proportion of Office Visits Made to Dermatologists Among Patients with Private 
Insurance. 
 
*The proportion of visits for all primary diagnoses by Hispanics increased significantly (β = 0.19, p = 0.003) among 
all those with private insurance during the study period. The number of privately insured dermatologic and non- 
dermatologic encounters totaled 3,125,989,800 visits during the 2005-2010 study period. 
Characteristics of Publicly and Privately Insured Visits 
Characteristics of visits attended by publicly and privately insured NHW, NHB and 
Hispanics for 2005-2010 are displayed in Tables 1 and 2. For both publicly and privately insured 
patients, visits by NHB and Hispanics were far less frequent than visits by NHW. 
Publicly insured visits made by NHB were most frequently done by females, patients 
older than 65, those living in metropolitan regions and those living in the South. Primary 
diagnoses for publicly insured visits by NHB were most often categorized in the “remaining 
diagnosis” (supplement) and most frequently were non-referred. Publicly insured visits made by 
Hispanics were also most often by females, those older than age 65, those living in metropolitan 
regions and those in the West. Primary diagnoses of publicly insured visits by Hispanics were 
most often categorized in the “remaining diagnosis” category. Publicly insured visits by NHW 
were more frequent among males, those older than age 65, those living in metropolitan regions 
and those living in the South. Primary diagnoses with publicly insured NHW were most 
frequently recorded as “pre-malignant and malignant conditions” and were most often non-
referred (Table 1).  
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Table 1. Characteristics of insured office-based visits to dermatologists by race, ethnicity and primary source of payment, 
United States, 2005-2010.* 
Public Insurance** 
 
 
All visits 
Weighted 
frequency  
(in 1000s) 
Standard 
of error 
% of 
visits 
Non-Hispanic 
whites 
Weighted 
frequency 
(in 1000s) 
Non-
Hispanic 
whites 
Standard 
of error 
% of 
visits 
Non-Hispanic 
Blacks 
Weighted 
frequency 
(in 1000s) 
Non-
Hispanic 
Black 
Standard 
of error 
% of 
visits 
Hispanics 
(in 1000s) 
Hispanics 
Standard of 
error 
% of 
visits 
Age 
All ages 61,759.6 5,011.8 100 55,066 4,721.3 100 2,694.8 637.9 100 3,173.6 765.7 100 
< 65 years old 7,584.8 1,140.8 12.3 5,515.7 840.5 10.0 1,211.4 376.4 45.0 794.3 298.1 25.0 
≥ 65years old 54,174 4,353 87.7 49,550.3 4,208.5 89.9 1,483.4 411.3 55.0 2,379.3 567.8 75.0 
Gender  
Female 31,165.2 2,712.8 50.5 27,085.4 2,438 49.2 1,759.6 488.6 65.3 1,807.6 564.5 57.0 
Male 30594.5 2,638.8 49.5 27,980.6 2,573.1 50.8 935.2 230.0 34.7 1,366.0 301.7 43.0 
Metropolitan Statistical Area (MSA) 
Metro 53,388.7 4,413.2 86.5 47,151.3 4,117.6 85.6 2,592.6 633.7 96.2 2,851.0 752.4 89.8 
Non-metro 8,371 2,370.8 13.6 7,914.7 2,315.2 14.4 102.3 76.3 3.8 322.5 142.5 10.2 
Geographic region 
Northeast 8,493.7 1,520.9 13.8 8,116.2 1,466.9 14.7 95.6 48.4 3.6 281.9 93.1 8.9 
Midwest 
14,540.
6 
2,252.7 23.5 13,442.1 2,224.6 24.4 666.6 319.6 24.7 369.8 139.5 11.7 
South 
25,626.
1 
3,671.2 41.5 22,473.2 3,388.3 40.8 1,748.4 545.7 64.9 1,236.9 651.6 39.0 
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*Data source: National Ambulatory Medical Care Survey (2005-2010) 
**Public Insurance includes Medicaid and Medicare, Medicare, or Medicaid/State Children’s Health Insurance Plan (SCHIP) 
***Premalignant and malignant: actinic keratosis, malignant neoplasm of skin-unspecified site, personal history of malignant neoplasm of the skin, malignant 
neoplasm of skin on the face 
****Inflammatory dermatoses: acne, dermatitis, psoriasis, and rosacea  
*****Other: benign neoplasm of skin-unspecified, seborrheic keratosis, verruca, neoplasm of uncertain behavior, sebaceous cyst, and unspecified disorder of the 
skin  
******Remaining diagnoses: all other primary diagnoses for office-based visits 
 
West 13,099.2 2,068.9 21.2 11,034.5 1,922.2 20.0 184.2 71.8 6.8 1,285.0 365.5 40.5 
Diagnoses 
Pre-malignant 
and 
Malignant*** 
19,949.7 1,943.9 32.3 19,016 1,944.9 34.5 273.2 122.4 10.1 656.1 176.9 20.7 
Inflammatory 
Dermatoses**
** 
8,051.2 848.5 13.0 6,408.2 726.4 11.6 870.2 269.1 32.3 490.6 133.6 15.5 
Other 
Diagnoses***
** 
16,309.7 1,718.1 26.4 14,782.5 1,604.3 26.9 536.7 179.8 19.9 633.4 167.7 20.0 
Remaining 
Diagnoses***
*** 
17,449 1,955.1 28.3 14,859.3 1,813.8 27.0 1,014.8 300.7 37.7 1,393.4 549.7 44.0 
Referral status 
Referred 
10,805.1 1,458 17.5 8,963.2 1,210.3 16.3 962.4 336.6 35.7 708.9 212.3 22.3 
Non-referred 
39,847 4,042 64.5 36,638.2 3,904.2 66.5 1,169.2 288.7 43.4 1,656.7 414.3 52.2 
Unknown or 
Blank 
11,107.6 1,307.4 18.0 9,464.6 1,169.3 17.2 563.3 207.4 20.9 807.9 356.8 25.5 
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Table 2. Characteristics of insured office-based visits to dermatologists by race, ethnicity and primary source of payment, United States, 
2005-2010.* 
Private Insurance** 
 
All visits 
Weighted 
frequency 
(in 1000s) 
Standard of 
error 
% of 
visits 
Non-Hispanic 
whites 
Weighted 
frequency 
(in 1000s) 
Non-
Hispanic 
whites 
Standard of 
error 
% of visits 
Non-
Hispanic 
Blacks 
Weighted 
frequency 
(in 1000s) 
Non-
Hispanic 
Blacks 
Standard of 
error 
% of 
visits 
Hispanics 
Weighted 
frequency 
(in 1000s) 
Hispanics 
Standard of 
error 
% of visits 
Age 
 
All ages 
128,852.7 9086.6 100 110,403.1 8,519.6 100 7,009.6 1,284.5 100 7,249.6 777.2 100 
< 65 years old 
116,453.7 8500.7 90.4 98,970.4 7,954.8 89.7 6,675.6 1,216.8 95.2 6,774.8 742.1 93.5 
≥ 65 years old 
12,399.0 1326.8 9.6 11,432.7 1,253.5 10.4 334 146.8 4.8 474.8 121.4 6.55 
Gender 
            
Female 
76,018.7 6016.7 59.0 64,197.5 5,610.6 58.2 4,921.7 986.0 70.2 4,343.9 520.9 57.0 
Male 
52,834.1 3547.5 41.00 46,205.6 3,335.6 41.9 2,087.8 400.3 29.8 2,905.6 410.0 43.0 
Metropolitan Statistical Area (MSA) 
Metro 
121,195.5 8,943.8 94.1 103,265.6 8,386.8 93.5 6,838.0 1,277.1 97.5 7,028.5 768.8 97.0 
Non-metro 
7,657.2 1,561.9 5.9 7,137.5 1,467.7 6.5 171.6 102.3 2.5 221.0 115.1 3.0 
Geographic region 
Northeast 
24,244.0 2,900.1 18.8 22,243.3 2,733.1 20.2 511.8 124.3 7.3 1,055.6 235.6 14.6 
Midwest 
32,442.9 4,828.2 25.2 29,440.4 4,703.1 26.7 1,408.9 586.7 20.1 766.9 187.6 10.6 
South 
46,445.0 6,521.8 36.1 38,913.1 6,035.4 35.3 4,359.6 1,113.1 62.2 2,404.6 490.7 33.2 
West 
25,720.8 2,784.9 20.0 19,806.3 2,498.0 17.9 729.3 2,06.5 10.4 3,022.5 522.3 41.7 
Diagnoses 
 
Premalignant 
and 
14,523.1 1,408.1 11.3 13,965.4 1,380.2 12.7 126.2 59.8 1.8 383.3 108.7 5.3 
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*Data source: National Ambulatory Medical Care Survey (2005-2010) 
**Includes visits exclusively with private insurance 
***Premalignant and malignant: actinic keratosis, malignant neoplasm of skin-unspecified site, personal history of malignant neoplasm of the skin, malignant 
neoplasm of skin on the face 
****Inflammatory dermatoses: acne, dermatitis, psoriasis, and rosacea  
*****Other: benign neoplasm of skin-unspecified, seborrheic keratosis, verruca, neoplasm of uncertain behavior, sebaceous cyst, and unspecified disorder of the 
skin  
******Remaining diagnoses: all other primary diagnoses for office-based visits 
 
Malignant*** 
Inflammatory 
Dermatoses**** 
37,865.5 2,891.6 29.34 30,230.7 2,595.6 27.4 2,800.4 573.4 40.0 2,850.6 410.3 39.3 
Other Diagnoses***** 
 
31,074.3 2,739.5 24.1 28,088.8 2,619.3 25.4 676.3 157.7 9.7 1,637.4 261.9 22.6 
Remaining 
Diagnoses****** 
45,389.9 3,347.6 35.2 38,118.3 3,122.8 34.5 3,406.7 724.5 49.0 2,378.2 344.3 32.8 
Referral status 
Referred 
30,548.0 3,146.6 23.7 25,208.7 2,728.4 22.8 2,106.7 858.2 30.1 2,040.5 364.2 28.2 
Non-referred 
73,845.1 6,890.5 57.3 64,798.4 6,430.5 58.7 3,366.6 611.6 48.0 3,634.9 528.9 50.1 
Unknown or Blank 
24,459.6 2,620.4 19.0 20,396.1 2,292.8 18.5 1,536.2 331.7 21.9 1,574.2 273.2 21.7 
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Privately insured visits by NHB were more common among those younger than 65 years, 
women, those living in metropolitan areas and those in the South. The most common primary 
diagnostic category for NHB was “remaining diagnoses,” and non-referred visits outnumbered 
referred visits. Visits by Hispanics were also more common in those younger than 65 years, 
women, those residing in metropolitan areas and those in the West. The most common primary 
diagnosis category was inflammatory dermatoses and non-referred visits outnumbered referred 
visits. Similarly, for privately insured NHW, visits were more frequent among patients younger 
than 65, women, metropolitan dwellers and those in the southern region. The most common 
primary diagnosis category was “remaining diagnosis” and non-referred visits were also more 
frequent than referred ones for privately insured NHW (Table 2). 
Racial and Ethnic Differences in Use of Publicly and Privately Insured Visits 
Dermatology visits were statistically significantly less likely to be made by publicly 
insured patients compared to privately insured ones, after adjustment for age, gender, geographic 
region, MSA status and primary diagnosis AOR (95% Confidence Interval [CI]) = 0.46 [0.39-
0.55]). Overall, publicly insured visits were less likely among NHB (62% lower odds) and 
Hispanics (54% lower odds) compared to NHW. However, NHB and Hispanics had 76% and 
64% lower odds, respectively, of making a non-referred visit compared to NHW, a statistically 
significant difference. Privately insured dermatology visits were also less likely among NHB 
(39% lower odds) and Hispanics (53% lower odds) than NHW. Similarly, privately insured NHB 
and Hispanics had 55% and 61% lower odds, respectively, of making a non-referred visit 
compared to NHW (Table 3).  
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*Data source: National Ambulatory Medical Care Survey, 2005-2010 
Multivariate analyses adjusted for age, gender, MSA status, geographic region and primary diagnoses.  
**Public Insurance: Medicaid and Medicare, Medicare, or Medicaid/State Children’s Health Insurance Plan 
(SCHIP).  
***Includes those with private insurance only 
^P Value <0.05 considered statistically significant.  
CI = confidence interval 
Table 3. Adjusted odds ratio (OR) of office-based dermatology visits by referral status. 
NAMCS, 2005-2010* 
 
Publically Insured** 
Race/Ethnicity 
Any Visit 
OR (95% 
CI) 
P 
Value
^ 
Referred 
OR (95% 
CI) 
P 
Value 
Non-Referred 
OR (95% CI) 
P 
Valu 
on-Hispanic 
Blacks 
0.38 (0.24, 
0.62) 
.0001 
1.54 (0.85, 
2.79) 
0.155 
0.24 (0.14, 
0.40) 
0.001 
Hispanics 
0.46 (0.26, 
0.80) 
.0063 
0.62 (0.28, 
1.36 
0.233 
0.36 (0.20, 
0.64) 
0.005 
Non-Hispanic 
whites 
1.0 
(reference) 
 
1.0 
(reference) 
 1.0 (reference)  
Privately Insured*** 
Race/Ethnicity 
Any Visit 
OR (95% 
CI) 
P 
Valu
e 
Referred 
OR (95% 
CI) 
P 
Value 
Non-Referred 
OR (95% CI) 
P 
Value 
Non-Hispanic 
Blacks 
0.61 (0.39, 
0.94) 
0.02
5 
1.24 (0.47, 
3.26) 
0.657 
0.45 (0.29, 
0.71) 
0.000
5 
Hispanics 
0.47 (0.35, 
0.63) 
<0.0
01 
0.64 (0.40, 
1.02) 
0.058 
0.39 (0.26, 
0.56) 
<0.00
1 
Non-Hispanic 
whites 
1.0 
(Reference) 
 
1.0 
(Reference) 
 
1.0 
(Reference) 
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Patterns of non-Referred Visit Diagnoses among whites and Minorities 
For publicly and privately insured NHW and minorities (NHB and Hispanics), non-
referred dermatology visits were more likely to be attributed to “pre-malignant and malignant” 
diagnoses than to ‘inflammatory” ones. Among NHW, visits were 55% more likely to be due to 
diagnoses in the “other” non-inflammatory diagnoses (including benign neoplasm of skin-
unspecified, seborrheic keratosis, verruca, neoplasm of uncertain behavior, sebaceous cyst and 
unspecified disorder of the skin) than to inflammatory diagnoses (Table 4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Data source: National Ambulatory Medical Care Survey, 2005-2010 
Multivariate analyses adjusted for age, gender, MSA status, geographic region and primary diagnoses 
**Pre-malignant and malignant: actinic keratosis, malignant neoplasm of skin-unspecified site, personal history of 
malignant neoplasm of the skin, malignant neoplasm of skin on the face 
***Other: benign neoplasm of skin-unspecified, seborrheic keratosis, verruca, neoplasm of uncertain behavior, 
sebaceous cyst, and unspecified disorder of the skin  
****Inflammatory dermatoses: acne, dermatitis, psoriasis, and rosacea  
^P Value <0.05 is considered statistically significant 
CI = confidence interval 
 
DISCUSSION 
In this study, we found that insured NHB and Hispanics were significantly less likely 
than their NHW counterparts to make outpatient dermatology visits in the US from 2005 to 2010. 
The proportion of visits by privately insured Hispanics increased during this time period. 
Racial/ethnic differences in utilization were the most profound among publicly insured patients 
and were observed only among non-professionally referred dermatology visits. These findings 
Table 4. Adjusted odds ratio (OR) of non-referred visits by primary diagnosis. 
NAMCS, 2005-2010.* 
  Visit Diagnosis Type 
Adjusted OR (95% 
CI) P Value^ 
Non-Hispanic whites 
 Pre-malignant and Malignant** 4.58 (3.27, 6.41) <0.001 
 Other*** 1.55 (1.28, 1.89) <0.001 
 Inflammatory dermatoses**** 1.0 (Reference)  
Non-Hispanic Blacks and Hispanics 
 Pre-malignant and Malignant** 4.48 (1.68, 11.94) 0.0027 
 Other*** 0.77 (0.50, 1.19) 0.2381 
 Inflammatory dermatoses**** 1.0 (Reference)  
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provide insights into potential mechanisms for ethnic and racial inequities in patient utilization of 
dermatology services, as well as racial/ethnic differences in dermatological clinical outcomes. 
To our knowledge, previous studies have not examined ethnic and racial differences in 
the use of dermatological services among insured patients in the US. Our results are consistent 
with findings from other disciplines of medicine, demonstrating that minorities are less likely to 
access health care services in general, including specialty services (Bisgaier & Rhodes, 2011; 
Heller et al., 2012; Levine et al., 2011). The reasons for these inequities among an insured 
patient population are not entirely clear. Several factors may play a role, including patients’ 
awareness of the need or preferences for dermatologic care, the practice patterns of referring 
healthcare providers (e.g., primary care providers) and/or insurance policies. In prior studies, 
minority patients demonstrated less awareness of sun-protective behaviors and routine skin 
cancer screenings compared to their white counterparts (Buster, You, Fouad, & Elmets, 2012; 
Cheng et al., 2010). 
Throughout all years, minorities (NHB and Hispanics) were less likely than NHW to seek 
dermatology care, with differences most profound among non-referred visits. Although both 
NHW and minorities made non-referred visits with pre-malignant and malignant diagnoses, 
NHW were more likely to make non-referred visits for “other diagnoses” relative to 
inflammatory diagnoses, while minorities were not. The reasons for the lower frequency of visits 
overall and for differences in non-referred visits are unclear. It is possible that minorities hold a 
higher threshold for seeking dermatologic care than non-minorities. Additional factors may 
include differences in preferences for dermatologic services, the recognition of dermatological 
conditions, competing health priorities and/or attitudes toward health care in general. Patients’ 
cultural perceptions, lack of necessary language skills, individual values concerning overall 
health and illness (Zuvekas & Taliaferro, 2003), use of folk medicines and fear of detecting 
cancer or other serious conditions have been proposed as reasons why minorities, such as 
African Americans, might be less likely to seek out the care of a dermatologist (McMichael & 
Jackson, 2000). Further, because minorities are at lower risk for the development of skin cancer, 
they may possess inherent cultural biases regarding the importance of dermatological health to 
their overall health (Cheng, et al., 2010). Prior studies have shown that limited English language 
fluency contributes to race/ethnicity disparities in the receipt of pediatric and psychiatric care 
(Fiscella, et al., 2002; Sentell, Shumway, & Snowden, 2007). The role of English language 
fluency in utilization and access to dermatologic care deserves further exploration. Our findings 
demonstrate no racial differences in the likelihood of having a referred dermatology visit, 
suggesting that primary provider referral practice patterns may be independent of race and 
ethnicity and may be more a consequence of the primary diagnosis chronicity and severity.  
More frequent dermatology visits and referrals among the privately insured may reflect 
differences in health insurance coverage for dermatology services as well as differences in the 
willingness of dermatologists to accept patients with public insurance. Bisgaier and Rhodes 
demonstrated significant disparities in access to specialists (including dermatologists) that was 
directly attributable to providers’ reluctance to accept patients with public insurance (Bisgaier & 
Rhodes, 2011). Furthermore, in dermatology practices accepting both private and public 
insurance plans, public insurance enrollees experienced longer average wait times than those 
with private insurance (Bisgaier & Rhodes, 2011). The low participation rates of dermatologists 
in public insurance programs may be attributable, in part, to low provider reimbursement rates, 
cumbersome administrative requirements, poor provider perceptions of programs, institutional or 
108  Racial and Ethnic Disparities in Dermatology Office Visits among Insured Patients, 2005-   
     2010 
     Harvey  
 
 
Journal of Health Disparities Research and Practice Volume 9, Issue 2 Summer 2016 
 http://digitalscholarship.unlv.edu/jhdrp/    
practice restrictions regarding program participation and/or financial constraints (Bisgaier & 
Rhodes, 2011; Bonito, et al., 2005; "Disparities," 2010). Our findings suggest that public 
insurance policies may improve the access of racial/ethnic minority patients to certain types of 
care (e.g., primary care) (Medicaid's Role for Black Americans, 2011; Medicaid's Role for 
Hispanic Americans, 2011) while inadvertently hindering their access to dermatology services, 
which corroborates similar findings on the lower use of other types of specialty services among 
minorities with public insurance (Bisgaier & Rhodes, 2011; Hargraves, Cunningham, & Hughes, 
2001). The influence of the Patient Protection and Affordable Care Act (ACA) on disparities in 
patients’ use of and access to dermatology services deserves further study. 
Our study has several limitations. First, despite the availability of numerous data 
elements within NAMCS to explore dermatology health services utilization, high non-response 
rates for race and ethnicity  required reliance on a large proportion of imputed data for the 
estimation of visit frequencies and calculation of adjusted odds ratios which may have altered 
our findings. (Cherry, et al., 2008; Cherry, et al., 2007; Hsiao, et al., 2010; Statistics, 2011a, 
2011b). Further, few visits were identified for patients who were “non-Hispanic other,” limiting 
our ability to explore differences with other racial/ethnic groups. Second, the relatively low 
number of dermatology visits within the NAMCS limited our ability to explore ethnic/race 
differences in dermatology service use among different forms of public insurance. We 
acknowledge the varying dermatological experience of Medicare and Medicaid beneficiaries. It 
is likely that dermatology service use varies among persons insured by Medicaid, Medicare and 
SCHIP, especially given the age distribution differences in these populations and their unique 
dermatologic needs. Nonetheless, prior studies exploring dermatology service use among 
patients with these different insurances have revealed similar findings, providing confidence in 
our approach (Stern, 2004). Third, the design of the NAMCS provides little information to assess 
the influence of varying levels of patient income or education on dermatology service use, 
factors implicated as highly important determinants of health care utilization in general, as well 
as in dermatology services in prior studies (Buster, et al., 2012; Sheehy et al., 2011; Zuvekas & 
Taliaferro, 2003). We were also unable to assess system-level barriers including intake 
procedures, physician hours and physicians’ administrative resources, all of which could 
influence the ability of physicians to see new minority and non-minority patients in dermatology 
care (Scheppers, van Dongen, Dekker, & Geertzen, 2006). Fourth, NAMCS contains limited data 
on clinical diagnoses for ambulatory care visits. Studies providing greater detail on the types of 
diagnoses and disease severity of patients utilizing dermatology services could better inform 
reasons for the disparities we observed in this study. Finally, we were unable to evaluated trends 
in utilization after the implementation of the ACA as this was unavailable during the time of our 
analysis. Future studies examining the impact of the ACA on utilization of and access to 
dermatologic services for the insured and uninsured are needed 
 
CONCLUSION 
 In summary, we observed racial/ethnic disparities in the use of dermatology services for 
both publicly insured and privately insured visits that were most profound among patients 
attending non-referred visits, which suggests that observed inequities may result from minority 
patients’ preferences or other factors (e.g., insurance coverage policies). Further studies 
examining the various patient, provider and system-related factors that influence the unequal 
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utilization of dermatology health services are important to identify mechanisms through which 
we can eliminate disparities in dermatological outcomes. 
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APPENDIX 
"Remaining" diagnoses, not included in definition for Malignant, Inflammatory and Other. 
 
 
    ICD-9-CM Diagnoses label Frequency Percent Cumulative Cumulative 
        Frequency Percent 
2169- Benign neoplasm of skin, site unspecified 293 12 731 29.93 
6918- Other atopic dermatitis and related conditions 59 2.42 1121 45.9 
69010 Seborrheic dermatitis, unspecified 56 2.29 1059 43.37 
V501- Other plastic surgery for unacceptable cosmetic 
appearance 
52 2.13 2168 88.78 
7098- Other specified disorders of skin 50 2.05 1860 76.17 
70909 Other dyschromia 49 2.01 1791 73.34 
V6709 Examination following other treatment 49 2.01 2302 94.27 
2165- Benign neoplasm of skin of trunk, except scrotum 46 1.88 430 17.61 
7011- Keratoderma, acquired 39 1.6 1411 57.78 
70401 Alopecia areata 38 1.56 1564 64.05 
0780- Molluscum contagiosum 35 1.43 127 5.2 
7048- Other specified diseases of hair and hair follicles 33 1.35 1616 66.18 
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2392- Neoplasms of unspecified nature of bone, soft tissue, and 
skin 
32 1.31 831 34.03 
7820- Rash and other nonspecific skin eruption 32 1.31 1961 80.3 
69279 Other dermatitis due to solar radiation 31 1.27 1193 48.85 
7014- Keloid scar 31 1.27 1452 59.46 
70900 Dyschromia, unspecified 29 1.19 1726 70.68 
1729- Malignant neoplasm of melanoma of skin, site unspecified 28 1.15 264 10.81 
70400 Alopecia, unspecified 27 1.11 1526 62.49 
V829- Special screening  for unspecified condition/Non-codable 
diagnosis/insuff. info for diagnosis 
27 1.11 2438 99.84 
V5831 Encounter for removal of sutures 26 1.06 2205 90.29 
1101- Dermatophytosis of nail 25 1.02 157 6.43 
6983- Lichenification and lichen simplex chronicus 24 0.98 1340 54.87 
7019- Unspecified hypertrophic and atrophic conditions of skin 24 0.98 1486 60.85 
75733 Congenital pigmentary anomalies of skin 24 0.98 1922 78.71 
V1209 Personal Hx of Infection/Parasitic diseases 
Unspecified/Personal history of diseases of skin unspecified 
24 0.98 2098 85.91 
6989- Unspecified pruritic disorder 23 0.94 1365 55.9 
V6759 Unspecified follow-up examination 22 0.9 2324 95.17 
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69589 Other specified erythematous conditions 21 0.86 1267 51.88 
69272 Acute dermatitis due to solar radiation 20 0.82 1156 47.34 
V0739 Other prophylactic chemotherapy 19 0.78 2066 84.6 
22800 Hemangioma of unspecified site 18 0.74 750 30.71 
1734- Malignant neoplasm of scalp and skin of neck 17 0.7 297 12.16 
7068- Other specified diseases of sebaceous glands 17 0.7 1665 68.18 
7092- Scar conditions and fibrosis of skin 17 0.7 1809 74.08 
1735- Malignant neoplasm of skin of trunk, except scrotum 16 0.66 313 12.82 
70901 Vitiligo 16 0.66 1742 71.33 
2329- Carcinoma in situ of skin, site unspecified 15 0.61 792 32.43 
6945- Pemphigoid 15 0.61 1232 50.45 
6959- Unspecified erythematous condition 15 0.61 1282 52.5 
7089- Urticaria, unspecified 15 0.61 1697 69.49 
V6549 Examination following surgery, unspecif 14 0.57 2239 91.69 
V6700 Examination following other surgery 14 0.57 2253 92.26 
0539- Herpes zoster without mention of complication 13 0.53 75 3.07 
1110- Pityriasis versicolor 13 0.53 201 8.23 
1991- Malignant neoplasm other w/o specification of site 13 0.53 344 14.09 
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6829- Other cellulitis and abscess of unspecified sites 13 0.53 967 39.6 
V741- Special screening for bac/spirochetal diseased: Pulmonary 
Tuberculosis 
13 0.53 2394 98.03 
0549- Herpes simplex without mention of complication 12 0.49 89 3.64 
2163- Benign neoplasm of skin of other and unspecified parts of 
face 
12 0.49 379 15.52 
5285- Diseases of lips 12 0.49 924 37.84 
684-- Impetigo 12 0.49 979 40.09 
6869- Unspecified local infection of skin and subcutaneous tissue 12 0.49 1003 41.07 
6970- Lichen planus 12 0.49 1310 53.64 
70581 Dyshidrosis 12 0.49 1635 66.95 
V711- Observation for suspected malignant neoplasm 12 0.49 2349 96.19 
1736- Malignant neoplasm of skin of upper limb including 
shoulder 
11 0.45 324 13.27 
22801 Hemangioma of skin and subcutaneous tissue 11 0.45 761 31.16 
7821 Rash and other nonspecific skin eruption 11 0.45 1972 80.75 
78261 Pallor 11 0.45 1986 81.33 
V681 Encounter for Admin Purposes: Rx refill 11 0.45 2336 95.66 
V7283 Other specified pre-op examination 11 0.45 2380 97.46 
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1105- Dermatophytosis of the body 10 0.41 180 7.37 
1732- Malignant neoplasm of skin of ear and external auditory 
canal 
10 0.41 280 11.47 
V6540 Counseling NOS 10 0.41 2225 91.11 
6954- Lupus erythematosus 9 0.37 1246 51.02 
7018- Other specified hypertrophic and atrophic conditions of 
skin 
9 0.37 1462 59.87 
7038- Other specified diseases of nail 9 0.37 1498 61.34 
919- Superficial Injury/multiple/unspec site 9 0.37 2026 82.96 
V820 Special screening for skin conditions 9 0.37 2406 98.53 
V221- Supervision of other normal pregnancy 8 0.33 2109 86.36 
1104- Dermatophytosis of foot 7 0.29 170 6.96 
1109- Dermatophytosis of unspecified site 7 0.29 188 7.7 
20210 Mycosis fungoides, unspec site, extranodal and solid organ 
sites 
7 0.29 352 14.41 
2299- Benign neoplasm of site unspecified 7 0.29 772 31.61 
6926- Contact dermatitis/eczema due to plants [except food] 7 0.29 1135 46.48 
69289 Other dermatitis or eczema due to other specified agents 7 0.29 1207 49.43 
70409 Other alopecia 7 0.29 1577 64.58 
117  Racial and Ethnic Disparities in Dermatology Office Visits among Insured Patients, 2005-   
     2010 
     Harvey  
 
 
Journal of Health Disparities Research and Practice Volume 9, Issue 2 Summer 2016 
 http://digitalscholarship.unlv.edu/jhdrp/    
71590 Osteoarthrosis, unspec generalized or localized, site unspec 7 0.29 1872 76.66 
V5832 Encounter for removal of sutures 7 0.29 2212 90.58 
V711- Observation for suspected malignant neoplasm 7 0.29 2356 96.48 
1737- Malignant neoplasm of skin of lower limb, including hip 6 0.25 330 13.51 
4481- Nevus, non-neoplastic 6 0.25 877 35.91 
68600 Pyoderma, unspecified 6 0.25 986 40.38 
69274 Other chronic dermatitis due to solar radiation 6 0.25 1162 47.58 
6962- Parapsoriasis 6 0.25 1288 52.74 
6963- Pityriasis rosea 6 0.25 1294 52.99 
7010- Circumscribed scleroderma 6 0.25 1372 56.18 
7012- Acquired acanthosis nigricans 6 0.25 1417 58.03 
70402 Telogen effluvium 6 0.25 1570 64.29 
7041- Hirsutism 6 0.25 1583 64.82 
70521 Primary focal hyperhidrosis 6 0.25 1623 66.46 
70583 Hidradenitis 6 0.25 1641 67.2 
7063- Seborrhea 6 0.25 1648 67.49 
7828- Changes in skin texture 6 0.25 1992 81.57 
V509- Attention to surgical dressings and s... 6 0.25 2178 89.19 
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V7189 Observation for unspecified suspected conditions 6 0.25 2362 96.72 
V727 Diagnostic skin and sensitization tests 6 0.25 2368 96.97 
1100- Dermatophytosis of scalp and beard 5 0.2 132 5.41 
1103- Dermatophytosis of groin and perianal area 5 0.2 163 6.67 
1123- Candidiasis of skin and nails 5 0.2 207 8.48 
1129- Candidiasis of unspecified site 5 0.2 212 8.68 
1330- Scabies 5 0.2 219 8.97 
2141- Lipoma of other skin and subcutaneous tissue 5 0.2 359 14.7 
2149- Lipoma, unspecified site 5 0.2 364 14.91 
2164- Benign neoplasm of scalp and skin of neck 5 0.2 384 15.72 
37331 Eczematous dermatitis of eyelid 5 0.2 857 35.09 
4489- Other and unspecified capillary diseases 5 0.2 882 36.12 
45981 Venous (peripheral) insufficiency, unspecified 5 0.2 895 36.65 
4720- Chronic rhinitis 5 0.2 907 37.14 
6809- Carbuncle and furuncle of unspecified site 5 0.2 939 38.45 
6819- Cellulitis and abscess of unspecified digit 5 0.2 945 38.7 
6930- Dermatitis due to drugs and medicines 5 0.2 1212 49.63 
7079- Chronic ulcer of unspecified site 5 0.2 1678 68.71 
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8789- Open wound(s) unspecified, complicated: Genital organs 
including traumatic amputation 
5 0.2 2010 82.31 
V500- Elective Procedure: Hair Transplant 5 0.2 2116 86.65 
V820- Special screening for unspecified conditions 5 0.2 2411 98.73 
2166- Benign neoplasm of skin of upper limb, including shoulder 4 0.16 434 17.77 
2167- Benign neoplasm of skin of lower limb, including hip 4 0.16 438 17.94 
2389- Neoplasm of uncertain behavior, site unspec. 4 0.16 799 32.72 
45989 Other specified disorders of circulatory system 4 0.16 899 36.81 
6923- Contact dermatitis/eczema due to drug and med in contact 
w/ skin 
4 0.16 1127 46.15 
69281 Dermatitis due to cosmetics 4 0.16 1197 49.02 
7013- Striae atrophicae 4 0.16 1421 58.19 
7088- Other specified urticaria 4 0.16 1682 68.88 
7100- Systemic lupus erythematosus 4 0.16 1864 76.33 
7571- Vascular hamartomas 4 0.16 1896 77.64 
7808- Disturbance of skin sensation 4 0.16 1929 78.99 
78900 Other ill-defined conditions 4 0.16 2000 81.9 
V1082 Personal Hx of malignant melanoma of skin 4 0.16 2070 84.77 
V109- Personal history of malignant neoplasm: Other, 4 0.16 2074 84.93 
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Gastrointestinal 
V508- Unspecelectiv surgery for purpose other then remedying 
health state 
4 0.16 2172 88.94 
5319 Gastric Ulcer: Unspecified acute/chronic, without mention 
of hemorrhage/perforation 
3 0.12 62 2.54 
1725- Malignant neoplasm of trunk, except scrotum 3 0.12 230 9.42 
1726- Malignant neoplasm of upper limb, including shoulder 3 0.12 233 9.54 
1727- Malignant neoplasm of lower limb, including hip 3 0.12 236 9.66 
1730- Malignant neoplasm of skin of lip 3 0.12 267 10.93 
1731- Malignant neoplasm of eyelid, including canthus 3 0.12 270 11.06 
22809 Hemangioma of other sites 3 0.12 764 31.29 
2323- Carcinoma in situ of skin of other and unspec parts of face 3 0.12 775 31.74 
2399- Neoplasms of unspecified nature site unspec 3 0.12 836 34.23 
2872- Other non-thrombocytopenic purpuras 3 0.12 848 34.73 
38000 Perichondritis of pinna, unspecified 3 0.12 862 35.3 
4476- Arteritis, unspecified 3 0.12 871 35.67 
4540- Varicose veins of lower extremities with ulcer 3 0.12 885 36.24 
6822- Other cellulitis and abscess of trunk 3 0.12 949 38.86 
6861- Pyogenic granuloma 3 0.12 991 40.58 
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69018 Other seborrheic dermatitis 3 0.12 1062 43.49 
6944- Pemphigus 3 0.12 1217 49.84 
6978- Other lichen, not elsewhere classified 3 0.12 1313 53.77 
6982- Prurigo 3 0.12 1316 53.89 
70710 Ulcer of lower limbs, exc decubitus,  3 0.12 1671 68.43 
71946 Brachia neuritis or radiculitis NOS 3 0.12 1878 76.9 
7273- Synovial cyst, unspecified 3 0.12 1886 77.23 
79989 Other specified cause/Other ill-defined condition 3 0.12 2003 82.02 
99832 Disruption/Dihiscence of external closure 3 0.12 2042 83.62 
V7643 Special screening for unspecified/other infectious disease: 
Skin 
3 0.12 2397 98.16 
1338- Other acariasis 2 0.08 221 9.05 
135-- Sarcoidosis 2 0.08 223 9.13 
2381- Neoplasm of uncertain behavior of connective and other 
soft tissue 
2 0.08 795 32.56 
2395- Neoplasms of unspecified nature other genitourinary 
organs 
2 0.08 833 34.11 
2449- Unspecified hypothyroidism 2 0.08 838 34.32 
4019- Unspecified essential hypertension 2 0.08 864 35.38 
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4541- Varicose veins of lower extremities with inflammation 2 0.08 887 36.32 
4659- Acute upper respiratory infections of unspecified site 2 0.08 902 36.94 
6920- Contact dermatitis/eczema of due to detergents 2 0.08 1123 45.99 
69282 Dermatitis due to other radiation 2 0.08 1199 49.1 
6940- Dermatitis herpetiformis 2 0.08 1214 49.71 
6949- Unspecified bullous dermatoses 2 0.08 1234 50.53 
6964- Pityriasis rubra pilaris 2 0.08 1296 53.07 
6965- Other and unspecified pityriasis 2 0.08 1298 53.15 
6984- Dermatitis factitia [artefacta] 2 0.08 1342 54.95 
7028- Other specified dermatoses 2 0.08 1488 60.93 
7069- Unspecified disease of sebaceous glands 2 0.08 1667 68.26 
71596 Arthropathy, unspecified, site unspecified 2 0.08 1874 76.74 
72691 Other bursitis 2 0.08 1883 77.11 
75732 Congenital pigmentary anomalies of skin 2 0.08 1898 77.72 
9194- Insect Bite, nonvenomous w/ out mention of infection 2 0.08 2028 83.05 
9596- Injury to unspecified site 2 0.08 2032 83.21 
9951- Other drug allergy 2 0.08 2035 83.33 
99889 Other specified complications of procedures 2 0.08 2045 83.74 
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V0481 Other prophylactic chemotherapy 2 0.08 2047 83.82 
V4589 Hair transplant 2 0.08 2111 86.45 
V992- Diagnosis of `none` 2 0.08 2441 99.96 
1700 Malignant Neoplasm of bone: Skull/Face -  1 0.04 57 2.33 
042-- Human immunodeficiency virus (HIV) disease 1 0.04 58 2.38 
0529- Varicella without mention of complication 1 0.04 59 2.42 
0540- Eczema herpeticum 1 0.04 76 3.11 
5419 Other genital herpes 1 0.04 77 3.15 
0559- Measles without mention of complication 1 0.04 90 3.69 
0578- Other specified viral exanthemata 1 0.04 91 3.73 
0579- Viral exanthem, unspecified 1 0.04 92 3.77 
1102- Dermatophytosis of hand 1 0.04 158 6.47 
1108- Dermatophytosis of other specified sites 1 0.04 181 7.41 
1120- Candidiasis of mouth 1 0.04 202 8.27 
1179- Other and unspecified mycoses 1 0.04 213 8.72 
1320- Pediculosis capitis [head louse] 1 0.04 214 8.76 
1600- Malignant neoplasm of nasal cavities 1 0.04 224 9.17 
1710- Malignant neoplasm connective/soft tissue: Head, Face, 1 0.04 225 9.21 
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Neck 
1723- Malignant neoplasm of other and unspec parts of face 1 0.04 226 9.25 
1724- Malignant neoplasm of scalp and neck 1 0.04 227 9.3 
1954- Malignant neoplasm of other ill-defined site: Upper Limb 1 0.04 331 13.55 
20190 Hodgkin`s dis, unspec, unspecsite, extranodal and solid 
organ sites 
1 0.04 345 14.13 
20280 Other lymphomas, unspec site, extranodal and solid organ 
sites 
1 0.04 353 14.46 
2107- Benign neoplasm of nasopharynx 1 0.04 354 14.5 
2150- Other benign neoplasm of head, face, and neck 1 0.04 365 14.95 
2160- Benign neoplasm of skin of lip 1 0.04 366 14.99 
2162- Benign neoplasm of ear and external auditory canal 1 0.04 367 15.03 
22389 Benign neoplasm of other urinary organs 1 0.04 732 29.98 
2298- Benign neoplasm of other specified sites 1 0.04 765 31.33 
2325- Carcinoma in situ of skin of trunk, except scrotum 1 0.04 776 31.78 
2326- Carcinoma in situ of skin of upper limb, including shoulder 1 0.04 777 31.82 
2349- Carcinoma in situ of site unspecified 1 0.04 793 32.47 
2564- Polycystic ovaries 1 0.04 839 34.36 
2648- Other manifestations of vitamin A deficiency 1 0.04 840 34.4 
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2722- Mixed hyperlipidemia 1 0.04 841 34.44 
2726- Lipodystrophy 1 0.04 842 34.48 
2727- Lipidoses 1 0.04 843 34.52 
2769- Electrolyte and fluid disorders not elsewhere classified 1 0.04 844 34.56 
2832- Hemoglobinuria due to hemolysis from external causes 1 0.04 845 34.6 
2911- Alcohol amnestic syndrome 1 0.04 849 34.77 
311-- Depressive disorder, not elsewhere classified 1 0.04 850 34.81 
3540- Carpal tunnel syndrome 1 0.04 851 34.85 
37230 Conjunctivitis, unspecified 1 0.04 852 34.89 
3739- Unspecified inflammation of eyelid 1 0.04 858 35.14 
37484 Cysts of eyelids 1 0.04 859 35.18 
4299- Heart disease, unspecified 1 0.04 865 35.42 
4378- Other cerebrovascular disease 1 0.04 866 35.46 
4460- Polyarteritis nodosa 1 0.04 867 35.5 
44629 Other specified hypersensitivity angiitis 1 0.04 868 35.54 
4542- Varicose veins of lower extremities w/ ulcer and 
inflammation 
1 0.04 888 36.36 
4549- Varicose vein of lower extremities w/o symptoms 1 0.04 889 36.4 
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4571- Other lymphedema 1 0.04 890 36.45 
4619- Acute sinusitis, unspecified 1 0.04 900 36.86 
4779- Allergic rhinitis cause unspecified 1 0.04 908 37.18 
49320 Chronic obstructive asthma/Asthma w/ COPD: unspecified 
asthmaticus or acute exacerbation 
1 0.04 909 37.22 
49390 Asthma, unspecified 1 0.04 910 37.26 
5238- Other specified periodontal diseases 1 0.04 911 37.31 
5282- Oral aphthae of the oral soft tissues 1 0.04 912 37.35 
5289- Other and unspecified diseases of the oral soft tissues 1 0.04 925 37.88 
53550 Unspecific gastritis/gastroduodenitis w/o mention of 
hemorrhage 
1 0.04 926 37.92 
5650- Anal fissure 1 0.04 927 37.96 
566-- Abscess of anal and rectal regions 1 0.04 928 38 
59010 Acute pyelonephritis without lesion of renal medullary 
necrosis 
1 0.04 929 38.04 
6071- Balanoposthitis 1 0.04 930 38.08 
6072- Other inflammatory disorders of penis 1 0.04 931 38.12 
6110- Inflammatory disease of breast 1 0.04 932 38.17 
64783 Other spec infec/parasite dis, antepartum condition or 
complication 
1 0.04 933 38.21 
127  Racial and Ethnic Disparities in Dermatology Office Visits among Insured Patients, 2005-   
     2010 
     Harvey  
 
 
Journal of Health Disparities Research and Practice Volume 9, Issue 2 Summer 2016 
 http://digitalscholarship.unlv.edu/jhdrp/    
65963 Other advanced maternal age, antepartum condition or 
complication 
1 0.04 934 38.25 
68102 Onychizia and paronychia of finger 1 0.04 940 38.49 
6820- Other cellulitis and abscess of face 1 0.04 946 38.74 
6823- Other cellulitis and abscess of upper arm and forearm 1 0.04 950 38.9 
6824- Other cellulitis and abscess of hand, except fingers and 
thumb 
1 0.04 951 38.94 
6825- Other cellulitis and abscess of buttock 1 0.04 952 38.98 
6826- Other cellulitis and abscess of leg, except foot 1 0.04 953 39.03 
6828- Other cellulitis and abscess of other specified parts 1 0.04 954 39.07 
6851- Pilonidal cyst without mention of abscess 1 0.04 980 40.13 
68601 Pyoderma gangrenosum 1 0.04 987 40.42 
68609 Other pyoderma 1 0.04 988 40.46 
6924- Contact dermatitis/eczema of due to other chemical 
products 
1 0.04 1128 46.19 
69271 Sunburn 1 0.04 1136 46.52 
69283 Dermatitis due to metals 1 0.04 1200 49.14 
6951- 6951- 1 0.04 1235 50.57 
69510 Erythema multiforme, unspecified/Erythema iris/Herpes 
iris 
1 0.04 1236 50.61 
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69519 Other erythema multiforme 1 0.04 1237 50.66 
700-- Corns and callosities 1 0.04 1366 55.94 
7015- Other abnormal granulation tissue 1 0.04 1453 59.5 
7030- Ingrowing nail 1 0.04 1489 60.97 
7039- Unspecified disease of nail 1 0.04 1499 61.38 
7051- Prickly heat 1 0.04 1617 66.22 
7060- Acne varioliformis 1 0.04 1642 67.24 
70700 Decubitus ulcer of unspecified site 1 0.04 1668 68.3 
70712 Ulcer of calf, exc decubitus 1 0.04 1672 68.47 
7078- Chronic ulcer of other specified sites 1 0.04 1673 68.51 
7091- Vascular disorders of skin 1 0.04 1792 73.38 
7093- Degenerative skin disorders 1 0.04 1810 74.12 
7103- Dermatomyositis/Poikildermatomyositis/Polymyositis w/ 
skin involvement 
1 0.04 1865 76.37 
71690 Arthropathy/Pain in joint, unspecified 1 0.04 1875 76.78 
7234- Brachia neuritis or radiculitis, unspecified 1 0.04 1879 76.95 
7244- Thoracic or lumbar sacral neuritis or radiculitis, 
unspecified 
1 0.04 1880 76.99 
72633 Olecranon Bursitis 1 0.04 1881 77.03 
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72740 Synovial cyst, unspecified 1 0.04 1887 77.27 
7286- Contracture of palmar fascia 1 0.04 1888 77.31 
7291- Myalgia and myositis 1 0.04 1889 77.35 
7292- Neuralgia, neuritis, and radiculitis, unspecified 1 0.04 1890 77.4 
72990 Disorders of Soft Tissue, unspecified 1 0.04 1891 77.44 
74429 Other specified anomalies of the ear 1 0.04 1892 77.48 
75739 Other specified anomalies of the skin 1 0.04 1923 78.75 
7804- Dizziness and giddiness 1 0.04 1924 78.79 
78079 Other malaise and fatigue 1 0.04 1925 78.83 
7822- Localized swelling, mass, or lump in skin 1 0.04 1973 80.79 
7823- Edema 1 0.04 1974 80.84 
7824- Jaundice, unspecified EXLUDING New Born 1 0.04 1975 80.88 
7829- Other symptoms involving skin/integument tissues 1 0.04 1993 81.61 
7842- Swelling, mass, or lump in head and neck 1 0.04 1994 81.65 
78605 Shortness of Breath 1 0.04 1995 81.7 
7862- Cough 1 0.04 1996 81.74 
7999- Unknown cause of morbidity/mortality 1 0.04 2004 82.06 
84210 Sprains and strains of hand: unspecified site 1 0.04 2005 82.1 
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8798- Open wound(s) of multiple unspecified sites, complicated 1 0.04 2011 82.35 
8820- Open wound of Hand EXCLUDING Finger, w/ out mention 
of complication 
1 0.04 2012 82.39 
8830- Open wound of Finger(s) 1 0.04 2013 82.43 
9100- Superficial Injury of face, neck, scalp EXCLUDING Eye: 
Abrasion or friction burn 
1 0.04 2014 82.47 
9104- Insect Bite, nonvenomous w/ out mention of infection: Face, 
Neck, Scalp 
1 0.04 2015 82.51 
9134- Insect Bite, nonvenomous w/ out mention of infection: 
Elbow, Forearm, Wrist 
1 0.04 2016 82.56 
9160- Superficial Injury of Hip, Thigh, Leg, Ankle: Abrasion or 
friction burn 
1 0.04 2017 82.6 
9198- Other unspecified superficial injury, multiple sites 1 0.04 2029 83.09 
9492- Burn w/ blisters and/or epidermal loss: 2nd Degree 1 0.04 2030 83.13 
9599- Angioneurotic edema 1 0.04 2033 83.25 
99527 Drug Allergy, NOS 1 0.04 2036 83.37 
9953- Allergy, Allergic rxn NOS 1 0.04 2037 83.42 
99779 Complications of Surg/Medical care: Vascular 
complications of other vessels, NOS 
1 0.04 2038 83.46 
99811 Hemorrhage complicating a procedure 1 0.04 2039 83.5 
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99859 Other post-op infection 1 0.04 2043 83.66 
V133- Personal history of other diseases of the skin and Subq 
tissue 
1 0.04 2099 85.95 
V1589 Personal history presenting hazards to health, NOS 1 0.04 2100 86 
V168- Personal Hx of Other specified malignant neoplasm 1 0.04 2101 86.04 
V583- Encounter for change or removal dressing/sutures 1 0.04 2179 89.23 
V5883 Encounter for therapeutic drug monitoring 1 0.04 2213 90.62 
V642- Surgical or other Procedure not carried out as decided by 
patient 
1 0.04 2214 90.66 
V643- Procedure not carried out for other reasons 1 0.04 2215 90.7 
V679- Unspecified follow-up examination 1 0.04 2325 95.21 
V700- Other specified general medical exam at health care facility 1 0.04 2337 95.7 
V727 Diagnostic skin and sensitization tests 1 0.04 2369 97.01 
V7285 Other specified examination 1 0.04 2381 97.5 
V990- Transferred to another facility, sent... 1 0.04 2439 99.88 
V997- Description not found 1 0.04 2442 100 
 
